← 返回

组织驻留记忆 T 细胞在肿瘤发生和癌症免疫治疗中的多方面功能

英文原题:Multifaceted functions of tissue-resident memory T cells in tumorigenesis and cancer immunotherapy.

查看英文原题

Multifaceted functions of tissue-resident memory T cells in tumorigenesis and cancer immunotherapy.

PubMed 2025/04/26(内容时间) Cancer Immunol Immunother Q1 · IF 5.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

组织驻留记忆T(T RM)细胞已被充分报道为非淋巴组织中抵御外来抗原的强大保护性第一道防线。此外,T RM细胞在抗肿瘤免疫中已证明具有关键的保护作用,有助于提高生存率并抑制多种癌症类型的肿瘤生长。然而,令人惊讶的是,近期研究表明T RM细胞可表现出矛盾效应,在特定条件下可能促进肿瘤进展,并在抗肿瘤免疫应答中导致不良结局。理解T RM细胞功能的复杂性将使我们能够更有效地利用其潜力推进癌症免疫治疗。因此,本综述全面探讨了T RM细胞在不同肿瘤背景下的双重作用,重点阐述其在抗击癌症中的保护功能以及其加剧肿瘤发展的不利潜力。此外,我们探讨了T RM细胞行为对未来癌症治疗策略的意义,强调需要进一步研究以优化T RM细胞的治疗性利用,同时减轻其有害效应。

展开英文摘要原文

Tissue-resident memory T (T RM ) cells are well reported as a strong protective first line of defense against foreign antigens in non-lymphoid tissues.

Moreover, T RM cells have demonstrated critical protective roles in antitumor immunity, contributing to enhanced survival and tumor growth inhibition across various cancer types.

However, surprisingly, recent studies suggest that T RM cells can exhibit paradoxical effects, potentially promoting tumor progression under certain conditions and leading to adverse outcomes during antitumor immune responses. Understanding the complexities of T RM cell functions will enable us to harness their potential in advancing cancer immunotherapy more effectively.

Therefore, this review comprehensively investigates the dual roles of T RM cells in different tumor contexts, highlighting their protective functions in combating cancers and their unfavorable potential to exacerbate tumor development.

Additionally, we explore the implications of T RM cell behaviors for future cancer treatment strategies, emphasizing the need for further research to optimize the therapeutic exploitation of T RM cells while mitigating their deleterious effects.

论文信息

作者
Seo ES、Lee SK、Son YM
第一作者单位
Department of Systems Biotechnology, Chung-Ang University, Anseong, 17546, Republic of Korea.South Korea
通讯作者单位
Department of Systems Biotechnology, Chung-Ang University, Anseong, 17546, Republic of Korea. Son0177@cau.ac.kr.South Korea
文献类型
综述
期刊
Cancer immunology, immunotherapy : CII2025 Apr 26
原文标识
PubMed 40285796 · DOI 10.1007/s00262-025-04035-x